- Home
- DRS vs LNTH Comparison
DRS vs LNTH Comparison
Compare DRS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRS
- LNTH
- Stock Information
- Founded
- DRS 1969
- LNTH 1956
- Country
- DRS United States
- LNTH United States
- Employees
- DRS N/A
- LNTH N/A
- Industry
- DRS Military/Government/Technical
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DRS Industrials
- LNTH Health Care
- Exchange
- DRS Nasdaq
- LNTH Nasdaq
- Market Cap
- DRS 8.3B
- LNTH 7.5B
- IPO Year
- DRS N/A
- LNTH 2015
- Fundamental
- Price
- DRS $41.67
- LNTH $81.24
- Analyst Decision
- DRS Buy
- LNTH Strong Buy
- Analyst Count
- DRS 6
- LNTH 5
- Target Price
- DRS $38.33
- LNTH $133.80
- AVG Volume (30 Days)
- DRS 1.1M
- LNTH 1.4M
- Earning Date
- DRS 05-01-2025
- LNTH 05-07-2025
- Dividend Yield
- DRS 0.43%
- LNTH N/A
- EPS Growth
- DRS 25.90
- LNTH N/A
- EPS
- DRS 0.88
- LNTH 3.53
- Revenue
- DRS $3,345,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- DRS $9.55
- LNTH $4.96
- Revenue Next Year
- DRS $6.15
- LNTH $10.25
- P/E Ratio
- DRS $47.35
- LNTH $23.00
- Revenue Growth
- DRS 13.58
- LNTH 12.53
- 52 Week Low
- DRS $21.98
- LNTH $74.34
- 52 Week High
- DRS $42.62
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- DRS 67.49
- LNTH 32.82
- Support Level
- DRS $40.01
- LNTH $77.01
- Resistance Level
- DRS $43.20
- LNTH $83.60
- Average True Range (ATR)
- DRS 1.59
- LNTH 3.77
- MACD
- DRS -0.07
- LNTH -2.21
- Stochastic Oscillator
- DRS 79.35
- LNTH 13.26
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.